Profit number beats Bloomberg estimate of Rs 75.7 crore. Sequentially net profit was up 5x
This approval is for a period of three months with effect from December 25, 2021 or till the appointment of a regular MD & CEO, whichever is earlier
Surpiya Lifescience is likely to make a bumper debut on the stock exchanges, with GMP indicating a likely listing gain of 40-45 per cent for the stock
The stock of the bank closed 18.32 per cent down to close at Rs 140.90 a piece on the BSE
The rating is constrained on account of moderation in asset quality parameters with high slippages in retail portfolio, mainly in unsecured retail loan portfolio owing to Covid-19
RBL Bank on Saturday said its Managing Director and Chief Executive Officer Vishwavir Ahuja has proceeded on leave with immediate effect
HP Adhesives is likely to debut with a 20-25 per cent listing gain, as per indications from the GMP
RBL's CEO goes on leave after the RBI appointed Yogesh K Dayal as an additional director of the bank.
A Death Cross, Descending triangle and a breach of significant levels reflect downside up to 16% for these banking shares
Nifty Bank was trading lower for the sixth straight day, having fallen 8 per cent during the period